Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

3096

Millipore

Bacterial Xpress Nucleic Acid Extraction Kit

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12161503
eCl@ss:
32161000

Hersteller/Markenname

Chemicon®

Qualitätsniveau

Methode(n)

DNA extraction: suitable

Anwendung(en)

sample preparation

Versandbedingung

wet ice

Allgemeine Beschreibung

Intended Use

The BacterialXpress nucleic acid extraction kit is intended for the purification of bacterial DNA from plasma, serum, cerebral spinal fluid, amniotic fluid, tissue, bone marrow, and cell culture. The BacterialXpress kit provides a rapid method for the extraction and purification of amplification-competent nucleic acids; however, the kit does not separate DNA from RNA. The BacterialXpress nucleic acid extraction kit can be used for the extraction and purification of a broad range of bacterial DNA from a variety of sources. However, performance cannot be guaranteed for all bacteria from all sources.

FOR LABORATORY USE ONLY; not for use in diagnostic procedures.

Anwendung

Research Category
All
Suitable for the purification of bacterial DNA from plasma, serum, cerebral spinal fluid, amniotic fluid, tissue, bone marrow, and cell culture.

Verpackung

50 Extractions

Komponenten

Bacterial DNA Extraction reagent - (Part No. 5539) - (1 bottle, 11.0 mL).

Lagerung und Haltbarkeit

BacterialXpress references a 2-8°C storage temperature, however, the product can also be stored at room temperature upon arrival. Product is stable up to the expiration date printed on the kit label at 2-8°C or at room temperature. Reagent will crystallize upon storage at 2-8°C and should be re-dissolved with gentle warming at 37° C before use.

WARNINGS AND PRECAUTIONS:

The BacterialXpress nucleic acid extraction reagent removes endogenous nucleases. Certified nuclease-free plasticware should be used whenever possible and work surfaces should be cleaned frequently with a diluted bleach solution to reduce the possibility for nuclease contamination.

Proper aseptic technique should be used when working with potentially infectious material. The BacterialXpress reagent contains a chaotropic salt, which is an irritant and is not compatible with disinfecting agents that contain bleach.

Dispose chaotropic salt containing solutions and plasticware according to your institutions waste-disposal guidelines.

The BacterialXpress reagent contains chaotropic salts, which may irritate the skin and damage clothing. As with any extraction procedure, use gloves, a laboratory coat and safety goggles. Avoid breathing vapors. In case of contact, immediately flush eyes or skin with a large amount of saline or water for at least 15 minutes.

DO NOT ALLOW THE EXTRACTION REAGENT TO COME IN CONTACT WITH BLEACH.

Rechtliche Hinweise

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General Lab Use

Piktogramme

CorrosionExclamation mark

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1 - Skin Corr. 1C

Zusätzliche Gefahrenhinweise

Lagerklassenschlüssel

8A - Combustible corrosive hazardous materials

WGK

WGK 2


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Fieke Lamers et al.
European journal of cancer (Oxford, England : 1990), 48(16), 3093-3103 (2012-03-01)
Genomic aberrations of key regulators of the apoptotic pathway have hardly been identified in neuroblastoma. We detected high BCL2 mRNA and protein levels in the majority of neuroblastoma tumours by Affymetrix expression profiling and Tissue Micro Array analysis. This BCL2

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.